We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.14B
1-Year Est. Return 139.27%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+139.27%
3 Year Est. Return
+309.04%
5 Year Est. Return
+400.83%
10 Year Est. Return
+1,509.99%
AUM
$2.04B
AUM Growth
+$786M
Cap. Flow
+$104M
Cap. Flow %
5.08%
Top 10 Hldgs %
76.01%
Holding
77
New
14
Increased
11
Reduced
15
Closed
7

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$67.7M
2
GLD icon
SPDR Gold Trust
GLD
+$43.9M
3
COUR icon
Coursera
COUR
+$12.4M
4
NEM icon
Newmont
NEM
+$8.79M
5
RGNX icon
Regenxbio
RGNX
+$5.25M

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.9%
2 Financials 7.26%
3 Materials 4.99%
4 Technology 4.3%
5 Communication Services 2.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBER icon
51
CALL
Uber
UBER
$145B
$3.57M 0.17%
+100,000
New +$3.6M
GME icon
52
PUT
GameStop
GME
$11.1B
$3.33M 0.16%
+80,000
New +$2.37M
ANGI icon
53
Angi Inc
ANGI
$215M
$2.92M 0.14%
51,472
CHWY icon
54
CALL
Chewy
CHWY
$8.4B
$2.85M 0.14%
+70,000
New +$3.18M
ASA
55
ASA Gold and Precious Metals
ASA
$1.05B
$2.74M 0.13%
122,351
BMRN icon
56
BioMarin Pharmaceuticals
BMRN
$12.5B
$2.39M 0.12%
30,953
JD icon
57
JD.com
JD
$36.3B
$2.29M 0.11%
+39,600
New +$2.69M
BIDU icon
58
Baidu
BIDU
$30.2B
$2.14M 0.11%
+16,200
New +$2.44M
NTLA icon
59
Intellia Therapeutics
NTLA
$1.61B
$1.94M 0.09%
26,646
FSR
60
PUT
DELISTED
Fisker Inc.
FSR
$1.94M 0.09%
150,000
+100,000
+200% +$1.25M
CRSP icon
61
CRISPR Therapeutics
CRSP
$5.05B
$1.19M 0.06%
18,876
RARE icon
62
Ultragenyx Pharmaceutical
RARE
$1.27B
$1.15M 0.06%
15,885
DAL icon
63
Delta Air Lines
DAL
$51.2B
$1.07M 0.05%
27,029
EDIT icon
64
Editas Medicine
EDIT
$416M
$548K 0.03%
28,797
SGMO
65
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$469K 0.02%
80,650
ADAP
66
DELISTED
Adaptimmune Therapeutics
ADAP
$238K 0.01%
115,602
CLLS
67
Cellectis
CLLS
$139M
$231K 0.01%
50,907
WVE icon
68
Wave Life Sciences
WVE
$887M
$85K ﹤0.01%
42,722
BLUE
69
DELISTED
bluebird bio
BLUE
$54K ﹤0.01%
561
ABEO icon
70
Abeona Therapeutics
ABEO
$307M
$29K ﹤0.01%
3,696
AMC icon
71
PUT
AMC Entertainment Holdings
AMC
$2.37B
-3,000
Closed -$816K
CAT icon
72
CALL
Caterpillar
CAT
$360B
-30,000
Closed -$6.2M
FCX icon
73
PUT
Freeport-McMoran
FCX
$99.4B
-50,000
Closed -$2.09M
GOOGL icon
74
PUT
Alphabet (Google) Class A
GOOGL
$4.19T
-50,000
Closed -$7.24M
NCLH icon
75
Norwegian Cruise Line
NCLH
$6.67B
-153,211
Closed -$3.18M

Similar funds

WS Management's Q1 2022 Portfolio in Review

As of Q1 2022, WS Management held 77 positions worth $2.04B, up 63% from $1.26B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

WS Management deployed $104M of net new capital in Q1 2022, opening 14 new positions and adding to 11 existing holdings. Its largest new stake was Invesco QQQ Trust: 190,488 shares worth $69.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 54% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Houghton Mifflin Harcourt Company, an estimated $24.8M trimmed.

  • WS Management's largest Q1 2022 buy was Invesco QQQ Trust: 190,488 shares worth $69.1M.
  • WS Management added most to SPDR Gold Trust in Q1 2022, an estimated $43.9M increase.
  • WS Management's biggest Q1 2022 reduction was Houghton Mifflin Harcourt Company, cutting an estimated $24.8M.
  • WS Management fully exited Netflix in Q1 2022, selling an estimated $4.82M.
  • WS Management's ten largest holdings make up 76% of its $2.04B portfolio in Q1 2022.
  • WS Management opened 14 new positions and closed 7 in Q1 2022.
  • WS Management's portfolio value rose 63% quarter-over-quarter to $2.04B.

Based on WS Management's 13F filing for Q1 2022, filed 12 May 2022.